Pembrolizumab-induced sarcoidal infusion site reaction

J Cutan Pathol. 2018 Jun 25. doi: 10.1111/cup.13307. Online ahead of print.

Authors

Robert J Smith¹, Tara C Mitchell², Emily Y Chu¹

Affiliations

¹ Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
² Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

PMID: 29938827
DOI: 10.1111/cup.13307

No abstract available

Keywords: PD-1 inhibitor; immune-related adverse events; pembrolizumab; sarcoidosis.